Positive allosteric modulators of highly Ca2+-permeable α7 nicotinic acetylcholine receptors, such as PNU-120596, may become useful therapeutic tools supporting neuronal survival and function. However, despite promising results, the initial optimism has been tempered by the concerns for cytotoxicity. The same concentration of a given nicotinic agent can be neuroprotective, ineffective or neurotoxic due to differences in the expression of α7 receptors and susceptibility to Ca2+ influx among various subtypes of neurons. Resolution of these concerns may require an ability to reliably detect, evaluate and optimize the extent of α7 somatic ionic influx, a key determinant of the likelihood of neuronal survival and function. In the presence of PNU-120596 and physiological choline (~10 μM), the activity of individual α7 channels can be detected in whole-cell recordings as step-like current/voltage deviations. However, the extent of α7 somatic influx remains elusive because the activity of individual α7 channels may not be integrated across the entire soma, instead affecting only specific subdomains located in the channel vicinity. Such a compartmentalization may obstruct detection and integration of α7 currents, causing an underestimation of α7 activity. By contrast, if step-like α7 currents are integrated across the soma, then a reliable quantification of α7 influx in whole-cell recordings is possible and could provide a rational basis for optimization of conditions that support survival of α7-expressing neurons. This approach can be used to directly correlate α7 single-channel activity to neuronal function. In this study, somatic dual-patch recordings were conducted using large hypothalamic and hippocampal neurons in acute coronal rat brain slices. The results demonstrate that the membrane electrotonic properties do not impede somatic signaling, allowing reliable estimates of somatic ionic and Ca2+ influx through α7 channels, while the somatic space-clamp error is minimal (~0.01 mV/μm). These research efforts could benefit optimization of potential α7-PAM-based therapies.
References
[1]
Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, et al. (2005) A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. JNeurosci 25: 4396–4405.
[2]
Faghih R, Gopalakrishnan SM, Gronlien JH, Malysz J, Briggs CA, et al. (2009) Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propion？yl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor. J Med Chem 52: 3377–3384.
[3]
Dinklo T, Shaban H, Thuring JW, Lavreysen H, Stevens KE, et al. (2011) Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]a？mino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor. J Pharmacol Exp Ther 336: 560–574.
[4]
Gusev AG, Uteshev VV (2010) Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-m？ethylisoxazol-3-yl)-urea]. J Pharmacol Exp Ther 332: 588–598.
[5]
Kalappa BI, Gusev AG, Uteshev VV (2010) Activation of functional alpha7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596. PLoS One 5: e13964.
[6]
Meyer EM, Tay ET, Papke RL, Meyers C, Huang G, et al. (1997) Effects of 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) on rat nicotinic receptors and memory-related behaviors. Brain Res 768: 49–56.
[7]
Li Y, Papke RL, He YJ, Millard WJ, Meyer EM (1999) Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells. Brain Res 830: 218–225.
[8]
Papke RL, Meyer E, Nutter T, Uteshev VV (2000) alpha 7 receptor-selective agonists and modes of alpha 7 receptor activation. European Journal of Pharmacology 393: 179–195.
[9]
Uteshev VV (2012) Alpha7 nicotinic ACh receptors as a ligand-gated source of Ca2+ ions: the search for a Ca2+ optimum. In: Islam MS, editor. Calcium Signaling Advances in Experimental Medicine and Biology, Vol. 740. Springer. In Press.
[10]
Del Barrio L, Martin-de-Saavedra MD, Romero A, Parada E, Egea J, et al. (2011) Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by alpha7 and beta2* nicotinic stimulation. Toxicol Sci 123: 193–205.
[11]
Kalappa BI, Feng L, Kem WR, Gusev AG, Uteshev VV (2011) Mechanisms of facilitation of synaptic glutamate release by nicotinic agonists in the nucleus of the solitary tract. Am J Physiol Cell Physiol 301: C347–361.
[12]
Uteshev VV, Stevens DR, Haas HL (1996) alpha-Bungarotoxin-sensitive nicotinic responses in rat tuberomammillary neurons. Pflugers Archiv-European Journal of Physiology 432: 607–613.
[13]
Uteshev V, Stevens DR, Haas HL (1995) A Persistent Sodium Current in Acutely Isolated Histaminergic Neurons from Rat Hypothalamus. Neuroscience 66: 143–149.
[14]
Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV (1998) Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. JNeurosci 18: 8228–8235.
